Skip to main content
. 2013 Mar;57(3):1209–1217. doi: 10.1128/AAC.01263-12

Table 2.

Urine pharmacokinetic parameters for GS-9851, GS-566500, and GS-331007

Drug and parameter Mean (SD) value for day and dosea
Day 1
Day 3
200 mg 400 mg 200 mg 400 mg
GS-9851
    Urine recovered (%)c 0.81 (0.66) 0.54 (0.41) 0.72 (0.46) 0.35 (0.31)
    Ae0–24 (mg) 1.61 (1.32) 2.14 (1.66) 1.44 (0.92) 1.40 (1.23)
    CLrenal (liters/min) 0.192 (0.078) 0.167 (0.090) 0.185 (0.059) 0.142 (0.096)
GS-566500
    Urine recovered (%)c 0.91 (0.95) 0.87 (0.63) 0.80 (0.37) 0.56 (0.26)
    Ae0–24 (mg) 1.42 (1.47) 2.70 (1.94) 1.23 (0.57) 1.70 (0.79)
    CLrenal (liters/min) 0.315 (0.241)b 0.223 (0.204) 0.449 (0.397) 0.272 (0.312)
GS-331007
    Urine recovered (%)c 26.22 (6.93) 14.01 (3.47) 38.45 (9.58) 25.81 (8.33)
    Ae0–24 (mg) 25.77 (6.81) 27.55 (6.83) 32.86 (8.38) 35.76 (8.01)
    CLrenal (liters/min) 0.178 (0.048) 0.172 (0.041) 0.194 (0.046) 0.183 (0.053)
a

Values are for 8 subjects except where otherwise noted.

b

n = 7.

c

Percentage of study drug excreted in urine. Values for GS-566500 and GS-331007 are presented as GS-9851 equivalents given the difference in molecular weights between GS-9851 and its metabolites.